Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc., 37525 [2018-16466]
Download as PDF
<![CDATA[
37525
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices
Controlled substance
Phenylacetone ................
Poppy Straw Concentrate.
Tapentadol ......................
Drug
code
Schedule
8501
9670
II
II
9780
II
The company plans to import narcotic
raw materials to manufacture bulk
controlled substances for distribution to
its customers. The company plans to
import an intermediate form of
tapentadol (9780), to bulk manufacture
tapentadol for distribution to its
customers.
Dated: July 23, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–16467 Filed 7–31–18; 8:45 am]
BILLING CODE 4410–09–P
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on July 3,
2018, Galephar Pharmaceutical
Research Inc., #100 Carr 198 Industrial
Park, Juncos, Puerto Rico 00777 applied
to be registered as an importer of the
following basic class of controlled
substance:
Drug
code
Controlled substance
DEPARTMENT OF JUSTICE
Hydromorphone ..............
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Galephar Pharmaceutical
Research Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 31, 2018. Such persons
may also file a written request for a
hearing on the application on or before
August 31, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
sradovich on DSK3GMQ082PROD with NOTICES
DATES:
VerDate Sep<11>2014
20:07 Jul 31, 2018
Jkt 244001
Schedule
9150
II
The company plans to import the
listed controlled substance in finished
dosage form for clinical trials, research
and analytical purposes.
Dated: July 23, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–16466 Filed 7–31–18; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Ultra Scientific Inc.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 31, 2018. Such persons
may also file a written request for a
hearing on the application on or before
August 31, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
DATES:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Controlled substance
Marihuana .......................
Tetrahydrocannabinols ...
DEPARTMENT OF JUSTICE
ACTION:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
4, 2018, Ultra Scientific Inc., 250 Smith
Street, North Kingstown, Rhode Island
02852 applied to be registered as an
importer of the following basic classes
of controlled substances:
Drug
code
Schedule
7360
7370
I
I
The company plans to import
derivatives of the listed controlled
substances for use as chemical
standards for testing and calibration
only of analytical equipment. The above
controlled substances will not be
imported for human or animal
consumption.
Dated: July 23, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–16465 Filed 7–31–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Anderson Brecon, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
DATES:
E:\FR\FM\01AUN1.SGM
01AUN1
]]>Agencies
[Federal Register Volume 83, Number 148 (Wednesday, August 1, 2018)]
[Notices]
[Page 37525]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16466]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Galephar
Pharmaceutical Research Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before August 31, 2018.
Such persons may also file a written request for a hearing on the
application on or before August 31, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been delegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on July
3, 2018, Galephar Pharmaceutical Research Inc., #100 Carr 198
Industrial Park, Juncos, Puerto Rico 00777 applied to be registered as
an importer of the following basic class of controlled substance:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Hydromorphone.......................... 9150 II
------------------------------------------------------------------------
The company plans to import the listed controlled substance in
finished dosage form for clinical trials, research and analytical
purposes.
Dated: July 23, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-16466 Filed 7-31-18; 8:45 am]
BILLING CODE 4410-09-P
